NeuroTalk Support Groups - A $63 billion biotech is returning to the scene of its worst failure in search of new

NeuroTalk Support Groups (https://www.neurotalk.org/)

- ALS News & Research (https://www.neurotalk.org/als-news-and-research/)

- - A $63 billion biotech is returning to the scene of its worst failure in search of new (https://www.neurotalk.org/als-news-and-research/252718-63-billion-biotech-returning-scene-worst-failure-search.html)

MuonOne

12-13-2018 02:57 PM

A $63 billion biotech is returning to the scene of its worst failure in search of new

A $63 billion biotech is returning to the scene of its worst failure in search of new treatments for a deadly muscle disorder

Biogen is adding ALS drugs to its research pipeline in search of blockbusters - Business Insider

. . . I did not realize Biogen was worth $63 million . . .

All times are GMT -5. The time now is 05:42 PM.